News

Filter

Current filters:

None

7970 to 7979 of 97893 results

Lilly's dulaglutide beats three other diabetes drugs in lowering blood sugar levels

22-10-2012

US pharma major Eli Lilly (NYSE: LLY) reported positive top-line results of three completed Phase III…

DiabetesdulaglutideEli LillyPharmaceuticalResearch

Orexigen gets FDA dispute response supportive of faster path to Contrave review

22-10-2012

The USA's Orexigen Therapeutics (Nasdaq: OREX) saw its shares jump 9.3% in early trading yesterday, after…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulationResearch

Chugai first to establish stable cell lines of cancer stem cells

22-10-2012

Chugai Pharmaceutical (TYO: 44519), which is majority-owned by Swiss drug major Roche (ROG: SIX), has…

Chugai PharmaceuticalOncologyPharmaceuticalResearchRoche

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region

22-10-2012

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

C4C consortium sets up France's ever facility for the industrialization of cell therapeutics

22-10-2012

The C4C consortium yesterday announced the implementation of France's first ever dedicated technical…

BiotechnologyEuropeFinancialProductionResearch

EMA panel backing for Novo Nordisk's Tresiba and Ryzodeg: Japanese review

22-10-2012

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on Friday announced…

Asia-PacificDegludecDiabetesEuropeNovo NordiskPharmaceuticalRegulationRyzodegTresiba

BioCryst and Presidio to merge, creating new competitor in HCV arena

22-10-2012

USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

Spanish pharma R&D dips below 1 billion euros

22-10-2012

In 2011, investment in R&D in the Spanish pharmaceutical industry fell below 1.0 billion-euro ($1.3 billion)…

BiotechnologyEuropeFinancialPharmaceuticalResearch

7970 to 7979 of 97893 results

COMPANY SPOTLIGHT

Menarini

Back to top